Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
NORTHBROOK, Ill., May 14, 2014 /PRNewswire/ -- Astellas reported today that the efficacy and safety data of the isavuconazole invasive aspergillosis study (SECURE) were presented at the European...
Eight abstracts will highlight enzalutamide studies in prostate and breast cancers NORTHBROOK, Ill. and SAN FRANCISCO, May 14, 2014 /PRNewswire/ -- Astellas Pharma US, Inc., a U.S. subsidiary of...
NORTHBROOK, Ill., May 2, 2014 /PRNewswire/ -- Astellas announces the promotion of Bernhardt Zeiher, M.D. ("Bernie") to the position of executive vice president, Global Development and the...
Read more about Astellas Announces Promotion and New Appointment
- Bloss to serve on Astellas US Management Committee - NORTHBROOK, Ill., April 16, 2014 /PRNewswire/ -- Astellas US LLC, a subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced...
Read more about Astellas US Promotes Jeffrey Bloss to SVP of Medical Affairs for the Americas
NORTHBROOK, Ill., April 16, 2014 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced today that it has reached an...
Read more about Astellas Pharma US, Inc. reaches agreement with U.S. Department of Justice
Follow U.S. news
